A detailed history of Graypoint LLC transactions in Organon & Co. stock. As of the latest transaction made, Graypoint LLC holds 10,467 shares of OGN stock, worth $160,040. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,467
Previous 14,555 28.09%
Holding current value
$160,040
Previous $278,000 43.88%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

SELL
$14.44 - $18.83 $59,030 - $76,977
-4,088 Reduced 28.09%
10,467 $156,000
Q3 2024

Oct 31, 2024

BUY
$18.65 - $23.03 $15,908 - $19,644
853 Added 6.23%
14,555 $278,000
Q2 2024

Jul 31, 2024

BUY
$17.45 - $21.96 $17,380 - $21,872
996 Added 7.84%
13,702 $283,000
Q1 2024

May 02, 2024

BUY
$13.78 - $18.8 $35,938 - $49,030
2,608 Added 25.83%
12,706 $238,000
Q4 2023

Jan 29, 2024

BUY
$10.95 - $17.32 $110,573 - $174,897
10,098 New
10,098 $145,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Graypoint LLC Portfolio

Follow Graypoint LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.